Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BI 1701963
i
Other names:
BI 1701963, BI-1701963, BI1701963
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Boehringer Ingelheim
Drug class:
SOS1 inhibitor, pan-KRAS inhibitor
Related drugs:
‹
BI-3406 (7)
RGT-018 (2)
MRTX0902 (0)
BI-2493 (4)
YL-17231 (1)
BI-3406 (7)
RGT-018 (2)
MRTX0902 (0)
BI-2493 (4)
YL-17231 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS mutation
Colorectal Cancer
KRAS mutation
Colorectal Cancer
trametinib + BI 1701963
Sensitive: D – Preclinical
trametinib + BI 1701963
Sensitive
:
D
trametinib + BI 1701963
Sensitive: D – Preclinical
trametinib + BI 1701963
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login